Discounted Cash Flow (DCF) Analysis Unlevered

Zomedica Corp. (ZOM)

$0.2041

+0.00 (+0.44%)
All numbers are in Millions, Currency in USD
Stock DCF: - | 0.2041 | undervalue

Operating Data

Year
A/P
2017
Actual
2018
Actual
2019
Actual
2020
Actual
2021
Actual
2022
Projected
2023
Projected
2024
Projected
2025
Projected
2026
Projected
Revenue ----------
Revenue (%)
EBITDA ----------
EBITDA (%)
EBIT ----------
EBIT (%)
Depreciation ----------
Depreciation (%)

Balance Sheet Data

Year
A/P
2017
Actual
2018
Actual
2019
Actual
2020
Actual
2021
Actual
2022
Projected
2023
Projected
2024
Projected
2025
Projected
2026
Projected
Total Cash ----------
Total Cash (%)
Account Receivables ----------
Account Receivables (%)
Inventories ----------
Inventories (%)
Accounts Payable ----------
Accounts Payable (%)
Capital Expenditure ----------
Capital Expenditure (%)

Weighted Average Cost Of Capital

Share price $ 0.2,041
Beta 0.739
Diluted Shares Outstanding 364.44
Cost of Debt
Tax Rate 11.26
After-tax Cost of Debt 0.39%
Risk-Free Rate
Market Risk Premium
Cost of Equity 6.995
Total Debt 1.38
Total Equity 74.38
Total Capital 75.76
Debt Weighting 1.82
Equity Weighting 98.18
Wacc

Build Up Free Cash

Year
A/P
2017
Actual
2018
Actual
2019
Actual
2020
Actual
2021
Actual
2022
Projected
2023
Projected
2024
Projected
2025
Projected
2026
Projected
Revenue ----------
EBITDA ----------
EBIT ----------
Tax Rate 0.00%0.00%0.00%0.00%11.26%2.25%2.25%2.25%2.25%2.25%
EBIAT ----------
Depreciation ----------
Accounts Receivable ----------
Inventories ----------
Accounts Payable ----------
Capital Expenditure -0.17-0.63-0.690.02-0.53-----
UFCF ----------
WACC
PV UFCF -----
SUM PV UFCF -

Terminal Value

Growth in perpetuity method:
Long-term growth rate
WACC (%) 6.87
Free cash flow (t + 1) -
Terminal Value -
Present Value of Terminal Value -

Intrinsic Value

Enterprise Value -
Net Debt -193.57
Equity Value -
Shares Outstanding 364.44
Equity Value Per Share -